Tyrosine phosphatase 3D structures
From Proteopedia
(Difference between revisions)
| Line 10: | Line 10: | ||
**[[5k9v]] – hPTPN1 - human<br /> | **[[5k9v]] – hPTPN1 - human<br /> | ||
**[[4qah]], [[4qap]], [[4qbe]], [[4qbw]], [[5kaa]], [[5ka8]], [[5ka4]], [[5ka2]], [[5ka1]], [[5ka0]] – hPTPN1 (mutant)<br /> | **[[4qah]], [[4qap]], [[4qbe]], [[4qbw]], [[5kaa]], [[5ka8]], [[5ka4]], [[5ka2]], [[5ka1]], [[5ka0]] – hPTPN1 (mutant)<br /> | ||
| - | **[[1a5y]], [[2hnp]], [[2hnq]], [[1oem]], [[1oeo]], [[1oes]], [[1oet]], [[1oeu]], [[1oev]], [[1sug]], [[2cm2]], [[2cm3]], [[3eu0]], [[3i80]], [[3a5j]], [[1bzc]], [[6b8e]], [[6b8t]], [[6b8x]], [[6b90]], [[6ntp]] - hPTP1B catalytic domain 1-321<br /> | + | **[[1a5y]], [[2hnp]], [[2hnq]], [[1oem]], [[1oeo]], [[1oes]], [[1oet]], [[1oeu]], [[1oev]], [[1sug]], [[2cm2]], [[2cm3]], [[3eu0]], [[3i80]], [[3a5j]], [[1bzc]], [[6b8e]], [[6b8t]], [[6b8x]], [[6b90]], [[6ntp]], [[6ol4]], [[6olq]], [[6olv]], [[6omy]], [[6pfw]], [[6pg0]], [[6pha]], [[6pgt]], [[6phs]], [[6pm8]] - hPTP1B catalytic domain 1-321<br /> |
**[[1gfy]], [[1i57]], [[1pa1]], [[2f6f]], [[3a5k]], [[3zv2]], [[3qkp]], [[3qkq]], [[6bai]], [[6olq]], [[6olv]], [[6omy]], [[6pfw]], [[6pg0]], [[6pgt]], [[6pha]], [[6phs]], [[6cwv]], [[6cwu]] - hPTP1B catalytic domain (mutant) <br /> | **[[1gfy]], [[1i57]], [[1pa1]], [[2f6f]], [[3a5k]], [[3zv2]], [[3qkp]], [[3qkq]], [[6bai]], [[6olq]], [[6olv]], [[6omy]], [[6pfw]], [[6pg0]], [[6pgt]], [[6pha]], [[6phs]], [[6cwv]], [[6cwu]] - hPTP1B catalytic domain (mutant) <br /> | ||
**[[3pdz]] - hPTP-1E PDZ2 domain – NMR<br /> | **[[3pdz]] - hPTP-1E PDZ2 domain – NMR<br /> | ||
| Line 117: | Line 117: | ||
**[[5ow1]], [[5ovx]], [[5ovr]] – hPTP5 catalytic domain + inhibitor<br /> | **[[5ow1]], [[5ovx]], [[5ovr]] – hPTP5 catalytic domain + inhibitor<br /> | ||
**[[4ge2]], [[4ge5]], [[4ge6]] – hPTP9 catalytic domain + inhibitor<br /> | **[[4ge2]], [[4ge5]], [[4ge6]] – hPTP9 catalytic domain + inhibitor<br /> | ||
| - | **[[3o5x]], [[4pvg]], [[5ehp]], [[5ehr]], [[4rdd]] – hPTPN11 catalytic domain + inhibitor<br /> | + | **[[3o5x]], [[4pvg]], [[5ehp]], [[5ehr]], [[4rdd]], [[7jvm]], [[7jvn]] – hPTPN11 catalytic domain + inhibitor<br /> |
**[[3mow]] - hPTPN11 catalytic domain + tautomycetin analog<br /> | **[[3mow]] - hPTPN11 catalytic domain + tautomycetin analog<br /> | ||
**[[2m10]] - hPTPN13 PDZ2 domain (mutant) + azobenzene derivative – NMR<br /> | **[[2m10]] - hPTPN13 PDZ2 domain (mutant) + azobenzene derivative – NMR<br /> | ||
| Line 141: | Line 141: | ||
**[[2gph]] - hPTPN7 catalytic domain (mutant) + MAPK2<br /> | **[[2gph]] - hPTPN7 catalytic domain (mutant) + MAPK2<br /> | ||
**[[4je4]], [[4jeg]] – hPTPN11 catalytic domain + monobody<br /> | **[[4je4]], [[4jeg]] – hPTPN11 catalytic domain + monobody<br /> | ||
| + | **[[6roz]], [[6roy]] – hPTPN11 N-SH2 domain + ITSM<br /> | ||
| + | **[[6r5g]] – hPTPN11 C-SH2 domain + ITSM<br /> | ||
**[[6iwd]] – hPTPN14 886-1187 + HPV18 CR3 domain<br /> | **[[6iwd]] – hPTPN14 886-1187 + HPV18 CR3 domain<br /> | ||
**[[5k25]], [[5k24]], [[5k23]] – hPTP PRL-2 + CNNM3<br /> | **[[5k25]], [[5k24]], [[5k23]] – hPTP PRL-2 + CNNM3<br /> | ||
| Line 183: | Line 185: | ||
*'''Human receptor-type tyrosine phosphatase''' | *'''Human receptor-type tyrosine phosphatase''' | ||
| + | **[[6uzt]] - hRPTP-α catalytic domain<br /> | ||
**[[2ahs]] – hRPTP-β<br /> | **[[2ahs]] – hRPTP-β<br /> | ||
**[[2i3r]], [[2i5x]] - hRPTP-β catalytic domain<br /> | **[[2i3r]], [[2i5x]] - hRPTP-β catalytic domain<br /> | ||
| Line 206: | Line 209: | ||
**[[2c9a]] - hRPTP-μ MAM-IG module<br /> | **[[2c9a]] - hRPTP-μ MAM-IG module<br /> | ||
**[[2v5y]] - hRPTP-μ extracellular region<br /> | **[[2v5y]] - hRPTP-μ extracellular region<br /> | ||
| - | **[[2g59]], [[2gjt]] - hRPTP-ο catalytic domain<br /> | + | **[[2g59]], [[2gjt]], [[6suc]], [[6sub]] - hRPTP-ο catalytic domain<br /> |
**[[2cfv]] – hRPTP-η residues 1019-1311<br /> | **[[2cfv]] – hRPTP-η residues 1019-1311<br /> | ||
**[[2nz6]] - hRPTP-η residues 1019-1311 (mutant) <br /> | **[[2nz6]] - hRPTP-η residues 1019-1311 (mutant) <br /> | ||
| Line 220: | Line 223: | ||
**[[5awx]] - hRPTP-ζ D1 domain<br /> | **[[5awx]] - hRPTP-ζ D1 domain<br /> | ||
**[[2qt7]], [[3n01]], [[3n4w]], [[3ng8]], [[3np5]] – hRPTP IA-2<br /> | **[[2qt7]], [[3n01]], [[3n4w]], [[3ng8]], [[3np5]] – hRPTP IA-2<br /> | ||
| - | **[[4n5u]] - hRPTP-F FN3 domain<br /> | + | **[[6tpv]] - hRPTP-F 1st-2nd FN3 domain 319-512<br /> |
| - | **[[2edx]] - hRPTP-F FN3 domain – NMR<BR /> | + | **[[6tpu]], [[6tpt]] - hRPTP-F 3rd-4th FN3 domain 513-705<br /> |
| + | **[[4n5u]] - hRPTP-F 4th FN3 domain 601-705<br /> | ||
| + | **[[2edx]] - hRPTP-F 4th FN3 domain – NMR<BR /> | ||
| + | **[[6tpw]] - hRPTP-F 1st-4th FN3 domain<br /> | ||
**[[6j6u]] - rRPTP-ζ D1-D2 domain<br /> | **[[6j6u]] - rRPTP-ζ D1-D2 domain<br /> | ||
**[[3jxg]], [[3jxh]] - mRPTP-γ CA-like domain<br /> | **[[3jxg]], [[3jxh]] - mRPTP-γ CA-like domain<br /> | ||
| Line 258: | Line 264: | ||
*'''Low molecular weight tyrosine phosphatase (LMW-PTP)''' | *'''Low molecular weight tyrosine phosphatase (LMW-PTP)''' | ||
| - | **[[1xww]], [[4z99]], [[5pnt]] - hLMW-PTP <br /> | + | **[[1xww]], [[4z99]], [[5pnt]], [[6y2w]], [[6y2v]] - hLMW-PTP <br /> |
**[[1phr]] - bLMW-PTP<br /> | **[[1phr]] - bLMW-PTP<br /> | ||
**[[1p8a]] – LMW-PTP (mutant) – ''Tritrichomonas foetus'' – NMR<BR /> | **[[1p8a]] – LMW-PTP (mutant) – ''Tritrichomonas foetus'' – NMR<BR /> | ||
Revision as of 11:13, 30 December 2020
3D Structures of tyrosine phosphatase
Updated on 30-December-2020 - For a general description of the protein see Tyrosine phosphatase
2shp, 6ihz, 6crf, 6cmp - hPTP SHP-2 (mutant)**1c0e – bPTP (mutant) – bovine
